
July 14, 2022
Fibrostenotic Crohnâs disease: Regulation of Fibrosis and inflammation with Cannabigerol and other cannabinoids
The goal of the project is to determine if the cannabis-derived, non-psychoactive compound, cannabigerol (CBG) (a key component of Cannabis), which is known to reduce inflammation in a mouse model of colon inflammation, can also prevent intestinal strictures (fibrosis) and narrowing of the intestine in the setting of intestinal inflammation. We will use cell culture […]
Read More